This grant supports investigator-initiated clinical trials to reduce cancer burden through early detection, prevention, and survivorship improvements.
Facilitates well-planned cancer prevention and control clinical trials by addressing information gaps to improve trial design and feasibility, saving time and money for NCI.
National Cancer Institute funds early phase clinical trials for cancer treatment and diagnosis, focusing on targeted interventions relevant to specific research programs.
This grant supports planning of cancer prevention and control clinical trials to enhance trial design, feasibility, and reduce costs for effective cancer interventions.
The National Cancer Institute funds cancer epidemiology cohort research on cancer causes and survivorship, including cohort upkeep, follow-up, and data and biospecimen sharing; clinical trials are not allowed.
This grant funds early-stage, highly innovative technology development projects to improve cancer research or clinical care, focusing on proof-of-concept studies with high potential impact in cancer-related fields.